✦ LIBER ✦

833 Malignancies in Children Receiving Infliximab and Other Inflammatory Bowel Disease Therapies: An Inflammatory Bowel Disease Multicenter, Prospective, Long-Term Registry of Pediatric Patients (Develop) Registry Data

✍ Scribed by Colletti, Richard B.; Cucchiara, Salvatore; Dubinsky, Marla; Escher, Johanna C.; Faubion, William A.; Fell, John; Gold, Benjamin D.; Griffiths, Anne M.; Hyams, Jeffrey S.; Koletzko, Sibylle; Kugathasan, Subra; Winter, Harland S.; Baldassano, Robert; Markowitz, James; Ruemmele, Frank; Callegari, Peter; Geldhof, Anja; Molenda, Mark R.; Tang, Kezhen L.; Wright, Richard; Veereman, Gigi

Book ID: 122185578
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 580 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60528-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P436 Malignancies in children receiving

P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data

✍ Colletti, R.; Cucchiara, S.; Dubinsky, M.; Escher, J.; Faubion, W.; Fell, J.; Go 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 66 KB

41 Serious Infections and Associated Ris

41 Serious Infections and Associated Risk Factors in Patients Receiving Infliximab and Immunotherapies for Children With Inflammatory Bowel Disease: Develop Registry Data

✍ Baldassano, Robert; Colletti, Richard B.; Cucchiara, Salvatore; Dubinsky, Marla; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 479 KB

15 Serious infections and associated ris

15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data

✍ Baldassano, R.; Colletti, R.; Cucchiara, S.; Dubinsky, M.; Escher, J.; Faubion, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 70 KB

S1241 Safety Profile of Infliximab in Ch

S1241 Safety Profile of Infliximab in Children with Inflammatory Bowel Disease (IBD): Pediatric Italian Registry of the Biological Therapy for IBD. Multicenter Study of the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP)

✍ Franca Viola; Massimiliano Paganelli; Alberto Ravelli; Paolo Lionetti; Arrigo Ba 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

OC3.11.3 SAFETY PROFILE OF INFLIXIMAB IN

OC3.11.3 SAFETY PROFILE OF INFLIXIMAB IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD): PEDIATRIC ITALIAN REGISTRY OF THE BIOLOGICAL THERAPY FOR IBD. MULTICENTER STUDY OF THE ITALIAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY HEPATOLOGY AND NUTRITION (SIGENP)

✍ Massimiliano Paganelli; V. Labalestra; A. Ravelli; P. Lionetti; A. Barabino; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 81 KB